225 related articles for article (PubMed ID: 15353600)
1. The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin.
Ungewickell A; Ward ME; Ungewickell E; Majerus PW
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13501-6. PubMed ID: 15353600
[TBL] [Abstract][Full Text] [Related]
2. Rab35 GTPase Triggers Switch-like Recruitment of the Lowe Syndrome Lipid Phosphatase OCRL on Newborn Endosomes.
Cauvin C; Rosendale M; Gupta-Rossi N; Rocancourt M; Larraufie P; Salomon R; Perrais D; Echard A
Curr Biol; 2016 Jan; 26(1):120-8. PubMed ID: 26725203
[TBL] [Abstract][Full Text] [Related]
3. Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network.
Choudhury R; Diao A; Zhang F; Eisenberg E; Saint-Pol A; Williams C; Konstantakopoulos A; Lucocq J; Johannes L; Rabouille C; Greene LE; Lowe M
Mol Biol Cell; 2005 Aug; 16(8):3467-79. PubMed ID: 15917292
[TBL] [Abstract][Full Text] [Related]
4. Clathrin terminal domain-ligand interactions regulate sorting of mannose 6-phosphate receptors mediated by AP-1 and GGA adaptors.
Stahlschmidt W; Robertson MJ; Robinson PJ; McCluskey A; Haucke V
J Biol Chem; 2014 Feb; 289(8):4906-18. PubMed ID: 24407285
[TBL] [Abstract][Full Text] [Related]
5. The 5-phosphatase OCRL mediates retrograde transport of the mannose 6-phosphate receptor by regulating a Rac1-cofilin signalling module.
van Rahden VA; Brand K; Najm J; Heeren J; Pfeffer SR; Braulke T; Kutsche K
Hum Mol Genet; 2012 Dec; 21(23):5019-38. PubMed ID: 22907655
[TBL] [Abstract][Full Text] [Related]
6. A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway.
Erdmann KS; Mao Y; McCrea HJ; Zoncu R; Lee S; Paradise S; Modregger J; Biemesderfer D; Toomre D; De Camilli P
Dev Cell; 2007 Sep; 13(3):377-90. PubMed ID: 17765681
[TBL] [Abstract][Full Text] [Related]
7. A role of OCRL in clathrin-coated pit dynamics and uncoating revealed by studies of Lowe syndrome cells.
Nández R; Balkin DM; Messa M; Liang L; Paradise S; Czapla H; Hein MY; Duncan JS; Mann M; De Camilli P
Elife; 2014 Aug; 3():e02975. PubMed ID: 25107275
[TBL] [Abstract][Full Text] [Related]
8. Structure and function of the Lowe syndrome protein OCRL1.
Lowe M
Traffic; 2005 Sep; 6(9):711-9. PubMed ID: 16101675
[TBL] [Abstract][Full Text] [Related]
9. A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism.
Mao Y; Balkin DM; Zoncu R; Erdmann KS; Tomasini L; Hu F; Jin MM; Hodsdon ME; De Camilli P
EMBO J; 2009 Jul; 28(13):1831-42. PubMed ID: 19536138
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Rab31 and OCRL-1 in oligodendrocytes: its role in transport of mannose 6-phosphate receptors.
Rodriguez-Gabin AG; Ortiz E; Demoliner K; Si Q; Almazan G; Larocca JN
J Neurosci Res; 2010 Feb; 88(3):589-604. PubMed ID: 19795375
[TBL] [Abstract][Full Text] [Related]
11. OCRL controls trafficking through early endosomes via PtdIns4,5P₂-dependent regulation of endosomal actin.
Vicinanza M; Di Campli A; Polishchuk E; Santoro M; Di Tullio G; Godi A; Levtchenko E; De Leo MG; Polishchuk R; Sandoval L; Marzolo MP; De Matteis MA
EMBO J; 2011 Oct; 30(24):4970-85. PubMed ID: 21971085
[TBL] [Abstract][Full Text] [Related]
12. SdhA blocks disruption of the Legionella-containing vacuole by hijacking the OCRL phosphatase.
Choi WY; Kim S; Aurass P; Huo W; Creasey EA; Edwards M; Lowe M; Isberg RR
Cell Rep; 2021 Nov; 37(5):109894. PubMed ID: 34731604
[TBL] [Abstract][Full Text] [Related]
13. Targeting of the type II inositol polyphosphate 5-phosphatase INPP5B to the early secretory pathway.
Williams C; Choudhury R; McKenzie E; Lowe M
J Cell Sci; 2007 Nov; 120(Pt 22):3941-51. PubMed ID: 17956944
[TBL] [Abstract][Full Text] [Related]
14. Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus.
Suchy SF; Olivos-Glander IM; Nussabaum RL
Hum Mol Genet; 1995 Dec; 4(12):2245-50. PubMed ID: 8634694
[TBL] [Abstract][Full Text] [Related]
15. Insights into the Effect of Lowe Syndrome-Causing Mutation p.Asn591Lys of OCRL-1 through Protein-Protein Interaction Networks and Molecular Dynamics Simulations.
Acosta-Tapia N; Galindo JF; Baldiris R
J Chem Inf Model; 2020 Feb; 60(2):1019-1027. PubMed ID: 31967472
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated Endocytosis 8 Utilizes an N-terminal Phosphoinositide-binding Motif to Regulate Endosomal Clathrin Dynamics.
Xhabija B; Vacratsis PO
J Biol Chem; 2015 Aug; 290(35):21676-89. PubMed ID: 26134565
[TBL] [Abstract][Full Text] [Related]
17. Sac2/INPP5F is an inositol 4-phosphatase that functions in the endocytic pathway.
Nakatsu F; Messa M; Nández R; Czapla H; Zou Y; Strittmatter SM; De Camilli P
J Cell Biol; 2015 Apr; 209(1):85-95. PubMed ID: 25869668
[TBL] [Abstract][Full Text] [Related]
18. The role of the Lowe syndrome protein OCRL in the endocytic pathway.
Sharma S; Skowronek A; Erdmann KS
Biol Chem; 2015 Dec; 396(12):1293-300. PubMed ID: 26351914
[TBL] [Abstract][Full Text] [Related]
19. [GGAs: structure and function of a novel family of clathrin adaptors involved in membrane trafficking between the TGN and endosomes].
Nakayama K; Wakatsuki S
Seikagaku; 2005 Nov; 77(11):1367-81. PubMed ID: 16370355
[No Abstract] [Full Text] [Related]
20. The DnaJ-domain protein RME-8 functions in endosomal trafficking.
Girard M; Poupon V; Blondeau F; McPherson PS
J Biol Chem; 2005 Dec; 280(48):40135-43. PubMed ID: 16179350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
